Sign in

You're signed outSign in or to get full access.

Vay Tham

Chief Revenue Officer at ALT5 Sigma
Executive

About Vay Tham

Vay Tham is Chief Revenue Officer (CRO) of ALT5 Sigma Corporation, appointed in June 2024; he was 51 as of December 28, 2024 and brings 20+ years across investment banking, capital raising, startups, and M&A execution . Under his commercial remit, ALT5 reported ALT5 Pay and ALT5 Prime surpassed US$2 billion in transaction volume in calendar 2024, marking a milestone for the fintech platforms . For broader pay-versus-performance context, ALT5’s 2023 disclosure shows the value of an initial $100 investment stood at $40.88 at year-end 2023 and net income was a loss of $7,812 thousand; see the table below .

Past Roles

OrganizationRoleYearsStrategic Impact
PI Financial CorporationManaging Director & Head of Technology Investment Banking2018–2024Led IB and M&A execution in technology, overseeing capital raising and transactions
Forge First Asset ManagementStrategic leadership (prior to PI Financial)Investment management and capital strategies; no specific dates disclosed
Cormark SecuritiesStrategic leadership (prior to PI Financial)Sell-side capital markets and deal execution; no specific dates disclosed
Waterfall InvestmentsStrategic leadership (prior to PI Financial)Investment and advisory; no specific dates disclosed
National Bank FinancialStrategic leadership (prior to PI Financial)Banking and M&A; no specific dates disclosed

External Roles

No external public-company directorships or committee roles for Vay Tham are listed in ALT5’s 10-K/DEF 14A materials reviewed .

Fixed Compensation

No disclosure of Vay Tham’s base salary, target bonus, or actual bonus in ALT5’s 2024 DEF 14A or 2024 10-K; he was not a named executive officer in the 2023 pay tables .

Performance Compensation

  • Company-wide equity framework: ALT5’s 2024 Equity Incentive Plan (approved Dec 2024) authorizes up to 2.8 million shares, covering stock awards, options, SARs, RSUs/PSUs, and other stock-based awards; minimum 1-year standard vesting, administrator discretion, and performance criteria may apply .
  • Change-of-control (COC) treatment: If awards are not assumed/substituted, unvested options/SARs vest on COC; time-based and performance-based stock awards fully vest or vest at target; if assumed, double-trigger vesting applies upon termination without cause within two years post-COC .
  • Termination provisions: Disability/death accelerate vesting with post-termination exercisability; retirement after 1 year continues vesting; other terminations forfeit unvested awards and limit exercisability; termination for cause cancels outstanding options/SARs .

No award grants specific to Vay Tham are disclosed in proxy/10-K materials reviewed .

Equity Ownership & Alignment

MetricOct 21, 2024Aug 12, 2025
Common shares beneficially owned— (listed as CRO; no stake shown) — (listed as CRO; no stake shown)
Ownership % of commonLess than 1% (*) Less than 1% (*)
Preferred shares (Series B/I/Q/S)Not listed Not listed

Additional alignment factors:

  • Hedging is prohibited for directors/officers/employees under company policy .
  • Transfer/pledging: Awards generally cannot be sold, pledged, assigned, or transferred prior to vesting/settlement, except by beneficiary designation or descent/distribution, and only to certain family transfers without consideration if permitted .
  • Executive lock-up: In Aug 2025, officers/directors entered lock-ups restricting sales of 50% of holdings for 90 days after the resale registration statement effective date and the remaining 50% upon the later of 90 days after effectiveness or stockholder approval of PIPE matters; this tempers near-term insider selling capacity .

Employment Terms

  • Appointment: Vay Tham was appointed ALT5’s CRO in June 2024 .
  • Employment agreement: No CRO-specific employment, severance, non-compete, non-solicit, or change-of-control cash severance terms are disclosed in filings reviewed .
  • Code of Ethics: ALT5 maintains a code of ethics for directors and senior officers and intends to disclose waivers per Item 5.05 on its website/8-K if applicable .
  • Award terms (if applicable): Company plan provides detailed vesting/termination and COC mechanics for equity awards (see Performance Compensation) .

Performance & Track Record

  • Fintech platform growth: ALT5 Pay and ALT5 Prime exceeded US$2 billion in transaction volume in calendar 2024, highlighting commercial momentum under the CRO function .
  • Pay vs performance context (company-level): See quantitative table below for TSR and net income disclosures .
MetricFY 2021FY 2022FY 2023
Value of initial $100 investment (TSR proxy)$83.64 $33.50 $40.88
Net Income ($USD thousands)($16,887) $10,992 ($7,812)

Compensation Committee & Governance

  • Compensation Committee: Comprised of independent directors; oversees officer salaries, equity awards, and bonuses. CEO comp recommended by Comp Committee and approved by Board; other officer comp recommended by CEO and approved by Comp Committee .
  • Board independence: Multiple directors are classified as independent under Nasdaq rules, with committee charters posted; Audit Committee chair recognized as financial expert .

Investment Implications

  • Pay-for-performance alignment: Absence of disclosed CRO-specific cash/equity metrics limits direct pay alignment analysis; however, company-wide plan features use performance criteria and double-trigger COC vesting, supporting at-risk equity design aligned with value creation .
  • Selling pressure/retention: Executive lock-ups (Aug–Nov 2025) restrict near-term insider sales, reducing technical selling pressure; standard award acceleration and retirement continuation provisions may aid retention, though CRO-specific severance economics are not disclosed .
  • Ownership alignment: CRO beneficial ownership is below 1% in disclosures reviewed, suggesting limited direct “skin-in-the-game”; hedging is prohibited and pledging restricted pre-vesting, mitigating misalignment risks .
  • Execution track record: Documented platform transaction growth to US$2B in 2024 provides an operational benchmark under revenue leadership; continued monitoring of revenue capture, client growth, and capital markets initiatives is warranted .